Copyright Reports & Markets. All rights reserved.

Global Argatroban Market Research Report 2012-2024

Request for Sample of this report
Buy now

Table of Contents

    1 Market Overview

    • 1.1 Objectives of Research
      • 1.1.1 Definition
      • 1.1.2 Specifications
    • 1.2 Market Segment
      • 1.2.1 by Type
        • 1.2.1.1 Argatroban Powder
        • 1.2.1.2 Argatroban Injection
      • 1.2.2 by Application
        • 1.2.2.1 Heparin-induced thrombocytopenia (HIT)
        • 1.2.2.2 Percutaneous Coronary Intervention
        • 1.2.2.3 Cerebral arterial thrombosis
      • 1.2.3 by Regions

    2 Industry Chain

    • 2.1 Industry Chain Structure
    • 2.2 Upstream
    • 2.3 Market
      • 2.3.1 SWOT
      • 2.3.2 Dynamics

    3 Environmental Analysis

    • 3.1 Policy
    • 3.2 Economic
    • 3.3 Technology
    • 3.4 Market Entry

    4 Market Segmentation by Type

    • 4.1 Market Size
      • 4.1.1 Argatroban Powder Market, 2013-2018
      • 4.1.2 Argatroban Injection Market, 2013-2018
    • 4.2 Market Forecast
      • 4.2.1 Argatroban Powder Market Forecast, 2019-2024
      • 4.2.2 Argatroban Injection Market Forecast, 2019-2024

    5 Market Segmentation by Application

    • 5.1 Market Size
      • 5.1.1 Heparin-induced thrombocytopenia (HIT) Market, 2013-2018
      • 5.1.2 Percutaneous Coronary Intervention Market, 2013-2018
      • 5.1.3 Cerebral arterial thrombosis Market, 2013-2018
    • 5.2 Market Forecast
      • 5.2.1 Heparin-induced thrombocytopenia (HIT) Market Forecast, 2019-2024
      • 5.2.2 Percutaneous Coronary Intervention Market Forecast, 2019-2024
      • 5.2.3 Cerebral arterial thrombosis Market Forecast, 2019-2024

    6 Market Segmentation by Region

    • 6.1 Market Size
      • 6.1.1 Asia-Pacific
        • 6.1.1.1 Asia-Pacific Market, 2012-2018
        • 6.1.1.2 Asia-Pacific Market by Type
        • 6.1.1.3 Asia-Pacific Market by Application
      • 6.1.2 North America
        • 6.1.2.1 North America Market, 2012-2018
        • 6.1.2.2 North America Market by Type
        • 6.1.2.3 North America Market by Application
      • 6.1.3 Europe
        • 6.1.3.1 Europe Market, 2012-2018
        • 6.1.3.2 Europe Market by Type
        • 6.1.3.3 Europe Market by Application
      • 6.1.4 South America
        • 6.1.4.1 South America Market, 2012-2018
        • 6.1.4.2 South America Market by Type
        • 6.1.4.3 South America Market by Application
      • 6.1.5 Middle East & Africa
        • 6.1.5.1 Middle East & Africa Market, 2012-2018
        • 6.1.5.2 Middle East & Africa Market by Type
        • 6.1.5.3 Middle East & Africa Market by Application
    • 6.2 Market Forecast
      • 6.2.1 Asia-Pacific Market Forecast, 2019-2024
      • 6.2.2 North America Market Forecast, 2019-2024
      • 6.2.3 Europe Market Forecast, 2019-2024
      • 6.2.4 South America Market Forecast, 2019-2024
      • 6.2.5 Middle East & Africa Market Forecast, 2019-2024

    7 Market Competitive

    • 7.1 Global Market by Vendors
    • 7.2 Market Concentration
    • 7.3 Price & Factors
    • 7.4 Marketing Channel

    8 Major Vendors

    • 8.1 Pfizer
    • 8.2 SANDOZ
    • 8.3 GlaxoSmithKline
    • 8.4 fresenius-kabi
    • 8.5 Eagle Pharmaceuticals
    • 8.6 Mitsubishi Tanabe Pharma
    • 8.7 Teva Pharmaceutical Industries
    • 8.8 WEST-WARD

    9 Conclusion

    Summary
    Argatroban is a synthetic direct thrombin inhibitor and the chemical name is 1-[5- [(aminoiminomethyl)amino]-1-oxo-2-[[(1,2,3,4-tetrahydro-3-methyl-8-quinolinyl)sulfonyl]amino]pentyl]-4-methyl-2-piperidinecarboxylic acid, monohydrate. Argatroban has 4 asymmetric carbons. One of the asymmetric carbons has an R configuration (stereoisomer Type I) and an S configuration (stereoisomer Type II). Argatroban consists of a mixture of R and S stereoisomers at a ratio of approximately 65:35.
    The global Argatroban market will reach xxx Million USD in 2019 with CAGR xx% 2019-2024. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
    Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
    Argatroban Powder
    Argatroban Injection
    Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
    Pfizer
    SANDOZ
    GlaxoSmithKline
    fresenius-kabi
    Eagle Pharmaceuticals
    Mitsubishi Tanabe Pharma
    Teva Pharmaceutical Industries
    WEST-WARD
    Based on Application, the report describes major application share of regional market. Application mentioned as follows:
    Heparin-induced thrombocytopenia (HIT)
    Percutaneous Coronary Intervention
    Cerebral arterial thrombosis
    Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
    Asia-Pacific
    North America
    Europe
    South America
    Middle East & Africa

    Buy now